Latest Period
Q1 2026
Security Snapshot
SINOVAC BIOTECH LTD. - Common Shares, par value US$0.001 per share (SVA) Institutional Ownership
CUSIP: P8696W104
13F Institutional Holders and Ownership History from Q1 2014 to Q1 2026
Institutions Reporting
9
Shares (Excl. Options)
8,970,122
Price
$6.47
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Shares, par value US$0.001 per share
- Symbol
- SVA on Nasdaq
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 8,970,122
- Total 13F value
- $224,912,807
- Portfolio coverage rank
- 0%
- Share change
- -19,362
- Value change
- -$406,460
- Number of holders
- 9
- Shares outstanding
- 71,872,133
- SEC-reported price per share
- $6.47
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
2 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- SVA - SINOVAC BIOTECH LTD. - Common Shares, par value US$0.001 per share is tracked under CUSIP P8696W104.
- 9 institutions reported positions in Q1 2026.
- 6 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 8 to 9 between Q4 2025 and Q1 2026.
- SEC-reported value moved from $40,853,096 to $224,912,807.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 9 institutions filings for Q1 2026.
Security key
P8696W104
Latest holder period
Q1 2026
13F holders
9
13D/G owners
6
CIK / CUSIP context first
Open Q1 2026 holders
SVA full holder history
SINOVAC BIOTECH LTD SEC filings
SINOVAC BIOTECH LTD company facts
SINOVAC BIOTECH LTD insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP P8696W104:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
6
Security
SVA
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| 1Globe Capital LLC | 32% | 0% | 18,515,315 | 0% | 1Globe Capital LLC | 07 Jul 2025 | ||
| SAIF Partners IV L.P. | 15% | 0% | 10,780,820 | 0% | SAIF Partners IV L.P. | 15 Dec 2025 | ||
| WEIDONG YIN | 8.8% | 0% | 6,359,500 | 0% | Weidong Yin | 10 Jul 2025 | ||
| Advantech Capital L.P. | 8.1% | 0% | 5,851,423 | 0% | Advantech Capital L.P. | 08 Jul 2025 | ||
| Vivo Capital VIII, LLC | 6.3% | 0% | 4,541,764 | 0% | Vivo Capital IX, LLC | 11 Jul 2025 | ||
| Vivo Capital IX, LLC | 6.3% | $293,522,587 | 4,539,456 | Vivo Capital IX, LLC | 17 Mar 2025 |
As of 31 Mar 2026, 9 institutional investors reported holding 8,970,122 shares of SINOVAC BIOTECH LTD. - Common Shares, par value US$0.001 per share (SVA). This represents 12% of the company’s total 71,872,133 outstanding shares.
13F concentration
Top 10 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
12%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| Vivo Capital, LLC | 8.2% | 5,903,000 | 0% | 3.2% | $38,192,410 |
| ORBIMED ADVISORS LLC | 3.8% | 2,718,735 | 0% | 4.2% | $184,466,170 |
| Neumann Advisory Hong Kong Ltd | 0.44% | 315,586 | 0% | 0.64% | $2,042,000 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.02% | 16,430 | 0% | 0% | $106,302 |
| MORGAN STANLEY | 0.01% | 9,144 | 0% | 0% | $59,161 |
| WELLS FARGO & COMPANY/MN | 0.01% | 4,811 | -71% | 0% | $31,127 |
| UBS Group AG | 0% | 2,229 | -76% | 0% | $14,422 |
| Horizon Investments, LLC | 0% | 104 | +100% | 0% | $673 |
| HARBOUR INVESTMENTS, INC. | 0% | 83 | 0% | $542 | |
| Aprio Wealth Management, LLC | 0% | 0 | -100% | $0 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
49
Latest
Q1 2026
Rows shown
1-25 of 49
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 8,970,122 | $224,912,807 | -$406,460 | $6.47 | 9 |
| 2025 Q4 | 6,270,749 | $40,853,096 | +$329,323 | $6.47 | 8 |
| 2025 Q3 | 8,982,045 | $224,989,943 | -$843,805 | $6.47 | 8 |
| 2025 Q2 | 10,293,731 | $375,364,173 | +$39,325,578 | $6.47 | 9 |
| 2025 Q1 | 3,034,321 | $336,038,595 | $64.66 | 2 | |
| 2024 Q4 | 3,034,321 | $336,038,595 | -$76,346,336 | $64.66 | 2 |
| 2024 Q3 | 14,834,373 | $418,388,336 | -$1,189,079 | $6.47 | 4 |
| 2024 Q2 | 13,494,548 | $79,577,415 | -$1,059,870 | $6.47 | 10 |
| 2024 Q1 | 12,345,841 | $79,877,748 | +$74,637,726 | $6.47 | 11 |
| 2023 Q4 | 3,035,348 | $345,241,022 | -$39,640,820 | $125.06 | 5 |
| 2023 Q3 | 6,591,632 | $41,683,415 | -$241,827 | $6.47 | 14 |
| 2023 Q2 | 654,395 | $4,040,321 | +$1,998,321 | $6.47 | 13 |
| 2023 Q1 | 8,934,321 | $957,411,410 | $104.30 | 3 | |
| 2022 Q4 | 6,846,776 | $44,307,000 | -$2,179,000 | $6.47 | 5 |
| 2022 Q3 | 6,549,095 | $42,402,000 | -$54,272 | $6.47 | 15 |
| 2022 Q2 | 6,556,811 | $43,219,000 | +$1,612,000 | $6.48 | 15 |
| 2022 Q1 | 6,307,855 | $41,615,000 | -$2,526,064 | $6.47 | 6 |
| 2021 Q4 | 6,703,614 | $43,337,796 | +$45,098 | $6.47 | 14 |
| 2021 Q3 | 6,692,031 | $43,303,000 | -$2,609 | $6.47 | 14 |
| 2021 Q2 | 17,473,080 | $448,658,000 | -$10,419 | $6.47 | 15 |
| 2021 Q1 | 6,694,343 | $43,301,798 | +$795,406 | $6.47 | 14 |
| 2020 Q4 | 19,723,128 | $113,774,000 | -$4,542 | $6.47 | 14 |
| 2020 Q3 | 6,567,108 | $42,490,000 | -$12,370 | $6.47 | 13 |
| 2020 Q2 | 6,569,021 | $42,502,000 | -$443,106 | $6.47 | 13 |
| 2020 Q1 | 9,476,962 | $60,096,177 | +$37,810,000 | $6.47 | 16 |